Article Details
Retrieved on: 2024-12-20 20:05:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Given the unmet need that is shown by both the ATTR-ACT LTE study [long-term extension of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial] ...
Article found on: www.endocrinologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here